Analyze Publications Database

The effect of chemotherapy on optic pathway gliomas and their sub-components: a volumetric MR analysis study

Shofty B, Mauda-Havakuk M, Weizman L, Constantini S, Ben-Bashat D, Dvir R, Pratt LT, Joskowicz L, Kesler A, Yalon M, Ravid L, Ben-Sira L. The effect of chemotherapy on optic pathway gliomas and their sub-components: a volumetric MR analysis study. Pediatr Blood Cancer. April 2015.

Publication Date
April 2015

How Analyze was Used
“Using the Analyze Software (Version 9.0 …), in a semi-automated fashion we measure the tumor volume and segment the tumor into three components: solid, non-enhancing; solid, enhancing component, and cystic.”

Keywords
Chemotherapy
Neurofibromatosis I (Nf1)
Optic Pathway Gliomas (OPG)
Pediatric

Author Affiliation(s)
The Gilbert Israeli Neurofibromatosis Center, Tel-Aviv Medical Center and The Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel. (BS, MMH, SC, LTP, AK, LR, LBS)

Pediatric Neurosurgery Dana Children’s Hospital, Tel-Aviv Medical Center and The Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel. (BS, SC)

Pediatric Radiology Unit, Tel-Aviv Medical Center and The Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel. (MMH, LTP, LBS)

Functional Brain Center, The Wohl Institute for Advanced Imaging, Tel-Aviv Medical Center and The Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel. (LW, LJ)

Pediatric Hematology-Oncology, Tel-Aviv Medical Center and The Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel. (DBB)

School of Engineering and Computer Science, The Hebrew University of Jerusalem, Jerusalem, Israel. (RD)

Pediatric Hematology Oncology, Sheba Medical Center, Tel-Hashomer, Israel. (MY)

ID# 2218

Tags: , , ,